| Absolute and relative benefits of statins | | |
| Interactive Training and Electronic Web Resource as Method to Increase the Level of Family Physicians Knowledge Concerning Implementation of Evidence-based Recommendations for Cardiovascular Risks Screening into Clinical Practice | | 2021 |
| ▼Inclisiran: more hope less hype | | 2022 |
| ▼Bempedoic acid: another cholesterol-lowering drug | Drug and Therapeutics Bulletin | 2022 |
| Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines | BMJ Open Diabetes Research and Care | 2022 |
| An independent external validation of the QRISK3 cardiovascular risk prediction model applied to UK Biobank participants | | |
| Achieving Lower LDL-C Levels After a Recent Myocardial Infarction Might Be Associated with Lower Healthcare Resource Use and Costs in Spain | Advances in Therapy | |
| Screening for Heart Disease in the Age of Digital Health Technologies: Who, When, and How? | | |
| Introduction to Clinical Prediction Models | Annals of Clinical Epidemiology | 2022 |
| Type 2 diabetes: summary of updated NICE guidance. | BMJ, The | 2022 |
| Cardiovascular Risk Stratification in Diabetic Retinopathy via Atherosclerotic Pathway in COVID-19/non-COVID-19 Frameworks using Artificial Intelligence Paradigm: A Narrative Review | Diagnostics | 2022 |
| Introducing multi-component cardiovascular health screening into existing Abdominal Aortic Aneurysm (AAA) screening programmes in the UK: a qualitative study of programme staff views. | BMC Health Services Research | 2022 |
| Long-Term Cardiovascular Risk and Management of Patients Recorded in Primary Care With Unattributed Chest Pain: An Electronic Health Record Study. | Journal of the American Heart Association | 2022 |
| Simvastatin is associated with superior lipid and glycaemic control to atorvastatin and reduced levels of incident Type 2 diabetes, in men and women, in the UK Biobank. | Endocrinology, Diabetes and Metabolism | 2022 |
| Polygenic scores in disease prediction: evaluation using the relevant performance metrics | | |
| Statin treatment effectiveness and the SLCO1B1*5 reduced function genotype: long-term outcomes in women and men. | British Journal of Clinical Pharmacology | 2022 |
| Dementia Risk Scores and Their Role in the Implementation of Risk Reduction Guidelines. | Frontiers in Neurology | 2021 |
| Increased burden of cardiovascular disease in people with liver disease: unequal geographical variations, risk factors and excess years of life lost. | Journal of Translational Medicine | 2022 |
| Nutraceuticals for the Control of Dyslipidaemias in Clinical Practice | Nutrients | 2021 |
| Determining propensity for sub-optimal low-density lipoprotein cholesterol response to statins and future risk of cardiovascular disease | PLoS ONE | 2021 |
| Triglyceride-rich Lipoprotein Cholesterol (Remnant Cholesterol) as a Therapeutic Target for Cardiovascular Disease Risk | Contemporary Cardiology | 2021 |
| Impact of changes to national guidelines on hypertension-related workload: an interrupted time series analysis in English primary care | British Journal of General Practice | 2021 |
| Cardiovascular Disease Risk in Women: What Makes It Different from Men | | 2017 |
| Cardiovascular risk in patients with type 2 diabetes: A systematic review of prediction models | Diabetes Research and Clinical Practice | 2021 |
| Patients' and health professionals' attitudes and perceptions towards the initiation of preventive drugs for primary prevention of cardiovascular disease: a systematic review of qualitative studies | BJGP Open | 2020 |
| GPs' familiarity with and use of cardiovascular clinical prediction rules: a UK survey study | BJGP Open | 2020 |
| American Heart Association's Cholesterol CarePlan as a Smartphone-Delivered Web App for Patients Prescribed Cholesterol-Lowering Medication: Protocol for an Observational Feasibility Study | JMIR Research Protocols | 2019 |
| Factors Associated With Engagement With a Web-Based Lifestyle Intervention Following Provision of Coronary Heart Disease Risk: Mixed Methods Study | Journal of Medical Internet Research | 2017 |
| Developing a synthetic national population to investigate the impact of different cardiovascular disease risk management strategies: A derivation and validation study | PLoS ONE | 2017 |
| Quantifying the contribution of statins to the decline in population mean cholesterol by socioeconomic group in England 1991 - 2012: a modelling study | PLoS ONE | 2015 |
| Evaluation of the uptake and delivery of the NHS Health Check programme in England, using primary care data from 9.5 million people: a cross-sectional study | BMJ Open | 2020 |
| An integrated polygenic and clinical risk tool enhances coronary artery disease prediction | | |
| SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes | Diabetes Therapy | 2020 |
| A comparison of approaches for combining predictive markers for personalised treatment recommendations | Trials | 2021 |
| Hyperlipidaemia | Medicine | 2021 |
| Effects of Statin Therapy and Dose on Cardiovascular and Limb Outcomes in Peripheral Arterial Disease: A Systematic Review and Meta-analysis | European Journal of Vascular and Endovascular Surgery | 2021 |
| Phytosterols and Cardiovascular Disease | Current Atherosclerosis Reports | 2021 |
| Risk Prediction of Cardiovascular Events by Exploration of Molecular Data with Explainable Artificial Intelligence | International Journal of Molecular Sciences | 2021 |
| Cardiovascular Risk Management in Type 1 Diabetes | Current Diabetes Reports | 2021 |
| Cardiovascular disease risk communication in NHS Health Checks: a qualitative video-stimulated recall interview study with practitioners | BJGP Open | 2021 |
| Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistanis and Bangladeshis | | |
| Development and validation of a cardiovascular risk prediction model in type 1 diabetes | Diabetologia | 2021 |
| Ethnic differences in guideline-indicated statin initiation for people with type 2 diabetes in UK primary care, 2006-2019: A cohort study | PLoS Medicine | 2021 |
| Uncovering undiagnosed liver disease: prevalence and opportunity for intervention in a population attending colonoscopy | BMJ Open Gastroenterology | 2021 |
| Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction | Circulation Genomic and Precision Medicine | 2021 |
| Survey on lipid diagnostics in Italy from the Working Group on Myocardial Markers (GdS MM) of the Italian Society of Clinical Pathology and Laboratory Medicine (SIPMeL): results and recommendations for reporting | Rivista Italiana Della Medicina Di Laboratorio | 2021 |
| The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: an Observational Cohort Study | Journal of General Internal Medicine | 2021 |
| Effectiveness of an Intervention Aimed at Improving Information for Patients with High Cardiovascular Risk: INFORISK Clinical Trial | International Journal of Environmental Research and Public Health | 2021 |
| Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses | PLoS Medicine | 2021 |
| Multiclass machine learning vs. conventional calculators for stroke/CVD risk assessment using carotid plaque predictors with coronary angiography scores as gold standard: a 500 participants study | International Journal of Cardiovascular Imaging | 2021 |
